Stock Events

Stock Events

Takeda Pharmaceutical 

€37.10
1210
-€1.54-3.99%Friday 07:05

Statistics

Day High
37.1
Day Low
37.1
52W High
38.64
52W Low
23.67
Volume
0
Avg. Volume
54
Mkt Cap
118.53B
P/E Ratio
307.08
Dividend Yield
3.09%
Dividend
1.15

Upcoming

Dividends

3.09%Dividend Yield
Dec 2026
€0.57
Jun 2026
€0.54
Dec 2025
€0.55
Jun 2025
€0.58
Dec 2024
€0.62
10Y Growth
-2.93%
5Y Growth
-4.71%
3Y Growth
-3.04%
1Y Growth
-8.72%

Earnings

Jan 28Expected
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
-0.13
0.14
0.41
0.69
Expected EPS
0.5030831743244719
Actual EPS
N/A

Financials

-3.17%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
25.18BRevenue
-798.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TKD.MU. It's not an investment recommendation.
Japan Tobacco
325
2914.TSE
Mitsubishi UFJ Financial Group
283
8306.TSE
NTT
239
9432.TSE
Mitsubishi HC Capital
226
8593.TSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company that competes with Takeda in various therapeutic areas, including oncology and immunology.
Novartis
NVS
Mkt Cap303.67B
Novartis is a multinational pharmaceutical company that competes directly with Takeda in areas such as cardiovascular, oncology, and neuroscience.
Merck
MRK
Mkt Cap368.89B
Merck is known for its strong presence in the pharmaceutical industry, competing with Takeda in oncology, vaccines, and infectious diseases.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes with Takeda in immunology, neuroscience, and oncology.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes with Takeda in the fields of immunology and oncology, with both companies having significant investments in research and development.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline competes with Takeda in respiratory, vaccines, and infectious disease, with a strong focus on research and development.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with Takeda in areas such as immunology, oncology, and rare diseases, with a broad portfolio of products.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes with Takeda in oncology and cardiovascular diseases, with both companies focusing on innovative treatments.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its pharmaceutical division, competes with Takeda in oncology, immunology, and infectious diseases, with a strong emphasis on biologics.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes with Takeda in several key areas including oncology, cardiovascular, and respiratory diseases, with a focus on innovation and targeted therapies.

About

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Show More
CEO
Julie So-Young Kim
Employees
47029
Country
Japan
ISIN
JP3463000004
WKN
000853849

Listings

MX
MX
TAKN.MX
STU
DE
TKD.STU
SA
BR
TAKP34.SA
MU
DE
TKDA.MU

0 Comments

Share your thoughts

FAQs

What is Takeda Pharmaceutical stock price today?▼
The current price of TKD.MU is €37.10 EUR — it has decreased by -3.99% in the past 24 hours. Watch Takeda Pharmaceutical stock price performance more closely on the chart.
What is Takeda Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Takeda Pharmaceutical stocks are traded under the ticker TKD.MU.
Is Takeda Pharmaceutical stock price growing?▼
TKD.MU stock has fallen by -0.4% compared to the previous week, the month change is a +14.79% rise, over the last year Takeda Pharmaceutical has showed a +56.74% increase.
What is Takeda Pharmaceutical market cap?▼
Today Takeda Pharmaceutical has the market capitalization of 118.53B
When is the next Takeda Pharmaceutical earnings date?▼
Takeda Pharmaceutical is going to release the next earnings report on January 28, 2027.
What were Takeda Pharmaceutical earnings last quarter?▼
TKD.MU earnings for the last quarter are 0.69 EUR per share, whereas the estimation was 0.26 EUR resulting in a +166.4% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Takeda Pharmaceutical revenue for the last year?▼
Takeda Pharmaceutical revenue for the last year amounts to 25.18B EUR.
What is Takeda Pharmaceutical net income for the last year?▼
TKD.MU net income for the last year is -798.99M EUR.
Does Takeda Pharmaceutical pay dividends?▼
Yes, TKD.MU dividends are paid semi-annual. The last dividend per share was 0.54 . As of today, Dividend Yield (FWD)% is 3.09%.
How many employees does Takeda Pharmaceutical have?▼
As of November 7, 2026, the company has 47,029 employees.
In which sector is Takeda Pharmaceutical located?▼
Takeda Pharmaceutical operates in the Health & Wellness sector.
When did Takeda Pharmaceutical complete a stock split?▼
Takeda Pharmaceutical has not had any recent stock splits.
Where is Takeda Pharmaceutical headquartered?▼
Takeda Pharmaceutical is headquartered in Tokyo, Japan.